IPO Issue Details
Issue Price / Price Band₹51 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size2,000 Shares per Lot
Total Issue Size14,30,000 shares (aggregating up to ₹7.29 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenMon, 30 Apr 2018
Subscription CloseThu, 03 May 2018
Anchor AllotmentSun, 29 Apr 2018
Basis of AllotmentWed, 09 May 2018
Initiation of RefundsThu, 10 May 2018
Credit of Shares to DematThu, 10 May 2018
Listing DateFri, 11 May 2018
UPI Mandate Deadline2018-05-03
Application & Investment Details
Retail — Min (1 Lots)₹1,02,000 — 2,000 shares
Retail — Max (13 Lots)₹1,326,000 (13 Lots)
HNI — Min (2 Lots)₹2,04,000 — 4,000 shares
Net Offer to Public13,56,000 shares (aggregating up to ₹6.92 Cr)
Reserved for Market Maker74,000 shares (aggregating up to ₹0.3774 Cr)
Pre-IPO Promoter Holding34,24,392 shares
Post-IPO Promoter Holding48,54,392 shares
About Indo US Bio-Tech Ltd.
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.The company started In-House Research and Development (R&D) unit at Modasa, District - Sabarkantha (Gujarat) for research activities to produce better and different varieties of seeds. On September 23, 2011, it got the recognition up to March 31, 2014, for In-House R&D from Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research Technology Bhavan, New Delhi (DSIR).In the initial stage, the company was engaged in producing different varieties of oilseeds and pulses seeds, later on, it also added vegetable, spices and cereals seeds to its basket. In the year 2014, it shifted its R&D unit Gandhinagar to carry on its research activities.As on January 31, 2018, Indo US Bio-Tech has 45 Employees in various departments.
Objects of the Issue
Indo US Bio-Tech Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Incremental Working Capital
5.04
2
2 General Corporate Purpose
1.80
Shareholding & Lock-in
Pre-IPO Promoter Holding
34,24,392 shares
Post-IPO Promoter Holding
48,54,392 shares